This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taha, M.-K.
Right arrow Articles by Alonso, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taha, M.-K.
Right arrow Articles by Alonso, J.-M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2002, p. 1083-1084, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1083-1084.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Neisseria meningitidis Serogroups W135 and A Were Equally Prevalent among Meningitis Cases Occurring at the End of the 2001 Epidemics in Burkina Faso and Niger

Muhamed-Kheir Taha,1 Isabelle Parent du Chatelet,2 Martin Schlumberger,2 Idrissa Sanou,3 Saacou Djibo,4 François de Chabalier,4 and Jean-Michel Alonso1*

Neisseria Unit, National Reference Centre for Meningococci, Institut Pasteur,1 Association pour l'Aide à la Médecine Préventive, 75724 Paris Cedex 15, France,2 Centre Hospitalier National Yalgado Ouedraogo, Ouagadougou 01, Burkina Faso,3 Centre de Recherche sur les Méningites et les Schistosomoses, Niamey, Niger4

Received 10 October 2001/ Returned for modification 5 November 2001/ Accepted 9 December 2001

Meningococcal infections occur as epidemics in the African meningitis belt. Neisseria meningitidis serogroup A is predominantly involved in these epidemics. We report here new data on the involvement of both serogroups A and W135 in meningitis cases in Burkina Faso and Niger at the end of the 2001 epidemic.

* Corresponding author. Mailing address: Neisseria Unit, National Reference Centre for Meningococci, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France. Phone: 33 1 45 68 83 30. Fax: 33 1 40 61 30 34. E-mail: jmalonso{at}pasteur.fr.

Journal of Clinical Microbiology, March 2002, p. 1083-1084, Vol. 40, No. 3
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.3.1083-1084.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Fraisier, C., Stor, R., Tenebray, B., Sanson, Y., Nicolas, P. (2009). Use of a New Single Multiplex PCR-Based Assay for Direct Simultaneous Characterization of Six Neisseria meningitidis Serogroups. J. Clin. Microbiol. 47: 2662-2666 [Abstract] [Full Text]  
  • Harrison, L. H. (2008). A Multivalent Conjugate Vaccine for Prevention of Meningococcal Disease in Infants. JAMA 299: 217-219 [Full Text]  
  • Nelson, C. B., Birmingham, M., Costa, A., Daviaud, J., Perea, W., Kieny, M.-P., Tarantola, D. (2007). Preparedness for Infectious Threats: Public-Private Partnership to Develop an Affordable Vaccine for an Emergent Threat: The Trivalent Neisseria meningitidis ACW135 Polysaccharide Vaccine. AJPH 97: S15-S22 [Abstract] [Full Text]  
  • Harrison, L. H. (2006). Prospects for Vaccine Prevention of Meningococcal Infection. Clin. Microbiol. Rev. 19: 142-164 [Abstract] [Full Text]  
  • Jin, Z., Bohach, G. A., Shiloach, J., Norris, S. E., Freedberg, D. I., Deobald, C., Coxon, B., Robbins, J. B., Schneerson, R. (2005). Conjugates of Group A and W135 Capsular Polysaccharides of Neisseria meningitidis Bound to Recombinant Staphylococcus aureus Enterotoxin C1: Preparation, Physicochemical Characterization, and Immunological Properties in Mice. Infect. Immun. 73: 7887-7893 [Abstract] [Full Text]  
  • Nicolas, P., Norheim, G., Garnotel, E., Djibo, S., Caugant, D. A. (2005). Molecular Epidemiology of Neisseria meningitidis Isolated in the African Meningitis Belt between 1988 and 2003 Shows Dominance of Sequence Type 5 (ST-5) and ST-11 Complexes. J. Clin. Microbiol. 43: 5129-5135 [Abstract] [Full Text]  
  • Al-Mazrou, Y., Khalil, M., Borrow, R., Balmer, P., Bramwell, J., Lal, G., Andrews, N., Al-Jeffri, M. (2005). Serologic Responses to ACYW135 Polysaccharide Meningococcal Vaccine in Saudi Children under 5 Years of Age. Infect. Immun. 73: 2932-2939 [Abstract] [Full Text]  
  • Nicolas, P., Djibo, S., Moussa, A., Tenebray, B., Boisier, P., Chanteau, S. (2005). Molecular Epidemiology of Meningococci Isolated in Niger in 2003 Shows Serogroup A Sequence Type (ST)-7 and Serogroup W135 ST-11 or ST-2881 Strains. J. Clin. Microbiol. 43: 1437-1438 [Abstract] [Full Text]  
  • Taha, M.-K., Giorgini, D., Ducos-Galand, M., Alonso, J.-M. (2004). Continuing Diversification of Neisseria meningitidis W135 as a Primary Cause of Meningococcal Disease after Emergence of the Serogroup in 2000. J. Clin. Microbiol. 42: 4158-4163 [Abstract] [Full Text]  
  • Tzeng, Y.-L., Noble, C., Stephens, D. S. (2003). Genetic Basis for Biosynthesis of the ({alpha}1->4)-Linked N-Acetyl-D-Glucosamine 1-Phosphate Capsule of Neisseria meningitidis Serogroup X. Infect. Immun. 71: 6712-6720 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»